In 2001, an estimated 150 million prescriptions, or 21 percent of prescriptions written, were for off-label use, according to the Archives study.
There is little question that what Dr. Gleason did was legal as companies can hire independent physicians to discuss he drugs and physicians are allowed to use FDA approved drugs for off label reasons.Maker of Narcolepsy Drug Pleads Guilty in U.S. Case
Maryland psychiatrist Peter Gleason pleads guilty in federal court in drug “misbranding” schemeXYREM(R) (sodium oxybate oral solution) net sales for the third quarter of 2008 increased 48 percent to $14.2 million, compared with $9.6 million for the third quarter of 2007.